x

PTF warns Nigerians against large purchase of hydroxychloroquine to treat COVID-19

Must read

The Presidential Task Force (PTF) on COVID-19 has warned Nigerians against buying hydroxychloroquine in large quantities to treat COVID-19, saying the drug had not been certified for use.

The Chairman of the PTF and the Secretary to the Government of the Federation (SGF), Boss Mustapha, said this at the PTF COVID-19 daily press briefing on Thursday in Abuja.

He said through the surveillance system set up by the PTF, it had received reports that Nigerians had been purchasing hydroxychloroquine in large quantities to treat the virus.

“We wish to reiterate that this drug has not being certified for use in treating COVID-19 in Nigeria by the relevant health and pharmaceutical authorities.

“Self-medication of any kind is fraught with the danger of increasing risks of avoidable casualties. We therefore strongly warn against self-medication,” he said.

According to him, “if you are sick, please seek medical advice and if you are confirmed positive, kindly self-isolate in an approved facility, the COVID-19 is highly infectious and dangerous.”

Although the World Health Organisation and other health experts have repeatedly warned that no drug has been approved for treating COVID-19 yet, statements by public officials including President Donald Trump of the U.S. and Governor Bala Mohammed of Bauchi State may have encouraged the mass purchase of chloroquine and its derivative, hydroxychloroquine, by Nigerians.

Mr Trump has repeatedly encouraged the use of the drug and said even he was using it. Mr Mohammed also said he had approved the use of the drug for COVID-19 patients in the state.

Copyright DAYBREAK.

All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from DAYBREAK NEWS.

More articles

1506 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest article